Skip to main content
Premium Trial:

Request an Annual Quote

Asterand Subsidiary to Screen Amylin Library

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Asterand today said that its BioSeek subsidiary will screen Amylin Pharmaceuticals' library of compounds to discover peptides with a potential for treating inflammatory conditions.

Under a one-year contract, BioSeek will apply its BioMap predictive human disease models to screen Amylin's library. The new deal builds on earlier similar agreements between the two firms involving peptide screening and related drug discovery activities.

The BioMap systems are cell-based models of human disease biology that are designed to replicate cell and pathway interactions as they are observed in human pharmacology and toxicology.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.